EU agency says clot ‘rare’ J&J side effect, as Europe vows more COVID doses
Europe’s medicines regulator said Tuesday that blood clots should be listed as a “very rare” side effect of Johnson & Johnson’s coronavirus vaccine, but that the benefits of the shot still outweigh the risks.